RU2111958C1 - Способ получения 7-(замещенный)-9-[(замещенный глицил)амидо]-6-диметил-6-деокситетрациклинов - Google Patents

Способ получения 7-(замещенный)-9-[(замещенный глицил)амидо]-6-диметил-6-деокситетрациклинов Download PDF

Info

Publication number
RU2111958C1
RU2111958C1 RU93043144A RU93043144A RU2111958C1 RU 2111958 C1 RU2111958 C1 RU 2111958C1 RU 93043144 A RU93043144 A RU 93043144A RU 93043144 A RU93043144 A RU 93043144A RU 2111958 C1 RU2111958 C1 RU 2111958C1
Authority
RU
Russia
Prior art keywords
methylpropyl
alpha
butyl
substituted
methyl
Prior art date
Application number
RU93043144A
Other languages
English (en)
Russian (ru)
Other versions
RU93043144A (ru
Inventor
Сум Файк-Енг
Дж.Ли Винг
Original Assignee
Американ Цианамид Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Американ Цианамид Компани filed Critical Американ Цианамид Компани
Publication of RU93043144A publication Critical patent/RU93043144A/ru
Application granted granted Critical
Publication of RU2111958C1 publication Critical patent/RU2111958C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU93043144A 1992-08-13 1993-08-12 Способ получения 7-(замещенный)-9-[(замещенный глицил)амидо]-6-диметил-6-деокситетрациклинов RU2111958C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/928588 1992-08-13
US07/928,588 US5284963A (en) 1992-08-13 1992-08-13 Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US07/928,588 1992-08-13

Publications (2)

Publication Number Publication Date
RU93043144A RU93043144A (ru) 1996-12-27
RU2111958C1 true RU2111958C1 (ru) 1998-05-27

Family

ID=25456483

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93043144A RU2111958C1 (ru) 1992-08-13 1993-08-12 Способ получения 7-(замещенный)-9-[(замещенный глицил)амидо]-6-диметил-6-деокситетрациклинов

Country Status (27)

Country Link
US (1) US5284963A (enExample)
EP (1) EP0582790B1 (enExample)
JP (1) JP3590643B2 (enExample)
KR (1) KR100250603B1 (enExample)
CN (1) CN1037680C (enExample)
AT (1) ATE174903T1 (enExample)
AU (1) AU674689B2 (enExample)
CA (1) CA2103837C (enExample)
CZ (1) CZ286261B6 (enExample)
DE (1) DE69322708T2 (enExample)
DK (1) DK0582790T3 (enExample)
ES (1) ES2125927T3 (enExample)
FI (1) FI115722B (enExample)
GR (1) GR3029764T3 (enExample)
HU (1) HU222886B1 (enExample)
IL (3) IL119551A (enExample)
LV (1) LV12273B (enExample)
MX (1) MX9304649A (enExample)
NO (1) NO303574B1 (enExample)
NZ (1) NZ248358A (enExample)
PH (1) PH30150A (enExample)
PL (2) PL173923B1 (enExample)
RU (1) RU2111958C1 (enExample)
SG (1) SG68556A1 (enExample)
SK (1) SK281698B6 (enExample)
TW (1) TW221285B (enExample)
ZA (1) ZA935891B (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
USRE40183E1 (en) 1991-10-04 2008-03-25 Wyeth Holdings Corporation 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
SG47520A1 (en) * 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5442059A (en) * 1992-08-13 1995-08-15 American Cyanamid Company 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
US5248797A (en) * 1992-08-13 1993-09-28 American Cyanamid Company Method for the production of 9-amino-6-demethyl-6-deoxytetracycline
EP1666453A1 (en) * 1999-09-14 2006-06-07 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6946118B1 (en) 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
AU2001268475A1 (en) * 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
EA006170B1 (ru) * 2000-07-07 2005-10-27 Трастис Оф Тафтс Коллидж Замещенные соединения тетрациклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния субъекта
SI1301467T1 (sl) 2000-07-07 2007-02-28 Tufts College 9-substituirane minociklinske spojine
US7094806B2 (en) 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US6683068B2 (en) * 2001-03-13 2004-01-27 Paratek Pharmaceuticals, Inc. 7, 9-substituted tetracycline compounds
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP1241160A1 (en) * 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
US20040063674A1 (en) 2001-07-13 2004-04-01 Levy Stuart B. Tetracycline compounds having target therapeutic activities
AU2002365120A1 (en) 2001-08-02 2003-07-15 Paratek Pharmaceuticals, Inc. Medicaments
JP2005514410A (ja) * 2002-01-08 2005-05-19 パラテック ファーマシューティカルズ インコーポレイテッド ４−デジメチルアミノテトラサイクリン化合物
JP2005526754A (ja) * 2002-03-08 2005-09-08 パラテック ファーマシューティカルズ インコーポレイテッド アミノメチル置換されたテトラサイクリン化合物
JP2005520846A (ja) 2002-03-21 2005-07-14 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物。
US20040029843A1 (en) * 2002-06-20 2004-02-12 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
EP2319828A3 (en) 2003-07-09 2011-07-06 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2287148A3 (en) 2004-10-25 2011-10-26 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
PA8652001A1 (es) 2004-11-05 2006-10-13 Wyeth Corp Metabolitos glucuronidos de tigeciclina y epimeros de los mismos
JP2008530023A (ja) * 2005-02-04 2008-08-07 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の１１ａ，１２−誘導体
US20060183758A1 (en) * 2005-02-17 2006-08-17 Cb Research And Development, Inc. Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
AR057033A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos para preparar 9-nitrominociclina
AR057649A1 (es) 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
AR057032A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Tigeciclina y metodos de preparacion
AR057034A1 (es) * 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina
AR057324A1 (es) * 2005-05-27 2007-11-28 Wyeth Corp Tigeciclina y metodos para preparar 9-aminominociclina
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
AU2006331685A1 (en) * 2005-12-22 2007-07-05 Wyeth Methods of treating gastrointestinal tract infections with tigecycline
WO2007120913A2 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
CN101479235B (zh) * 2006-04-24 2013-09-18 特瓦制药工业有限公司 替加环素晶形及其制备方法
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
AU2007249695A1 (en) 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
US20070286818A1 (en) * 2006-06-07 2007-12-13 Wyeth Treating cystic fibrosis with antibiotics via an aerosol drug
US20070286817A1 (en) * 2006-06-07 2007-12-13 Wyeth Treating cystic fibrosis with antibiotics via a swirler delivery
US20080039433A1 (en) * 2006-06-15 2008-02-14 Smith Alexander D Stabilized Tetracycline Compositions
EP2236491A3 (en) 2006-11-29 2010-11-03 Teva Pharmaceutical Industries, Ltd. Crystalline form of tigecycline and processes for preparation thereof
BRPI0706517A2 (pt) * 2006-11-30 2011-03-29 Teva Pharma processos para preparação de f 9-haloacetamidominociclinas
EP2114865A1 (en) * 2007-03-01 2009-11-11 Teva Pharmaceutical Industries Ltd. Processes for purification of tigecycline
AT13157U1 (de) * 2007-04-24 2013-07-15 Teva Pharma Tigecyclin, kristalline Formen und Herstellungsverfahren dafür
US20090076153A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched tigecycline
AU2008331163B2 (en) 2007-11-29 2014-01-30 Viatris Asia Pacific Pte. Ltd. Phosphonic acid derivates and their use as P2Y12 receptor antagonists
CN103936645B (zh) 2008-08-08 2016-03-09 四相制药公司 C7-氟取代的四环素化合物
CA2761241C (en) 2009-05-08 2018-02-27 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
US9624166B2 (en) 2009-08-28 2017-04-18 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
HUE042600T2 (hu) 2012-08-31 2019-07-29 Tetraphase Pharmaceuticals Inc Tetraciklin vegyületek
EP3529236B1 (en) 2016-10-19 2024-02-07 Tetraphase Pharmaceuticals, Inc. Crystalline forms of eravacycline
EP3976050B1 (en) 2019-05-24 2025-01-22 Stichting Radboud universitair medisch centrum Improved administration of glycylcyclines by inhalation for the treatment of pulmonary infections with mycobacterium abscessus

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE26271E (en) * 1967-09-26 Reductive alkylation process
US2482055A (en) * 1948-02-11 1949-09-13 American Cyanamid Co Aureomycin and preparation of same
US3007965A (en) * 1959-02-13 1961-11-07 American Cyanamid Co New tetracyclines produced by streptomyces aureofaciens
US3043875A (en) * 1959-10-22 1962-07-10 Pfizer & Co C Halogenated tetracycline derivatives and processes for their preparation
FR1430859A (enExample) * 1960-05-23 1966-05-25
US3338963A (en) * 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
US3360557A (en) * 1963-05-10 1967-12-26 American Cyanamid Co 9-hydroxytetracyclines and a process of preparing same
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3341585A (en) * 1966-05-06 1967-09-12 American Cyanamid Co Substituted 7-and/or 9-amino-6-deoxytetracyclines
US3360561A (en) * 1967-06-19 1967-12-26 American Cyanamid Co Nitration of tetracyclines
US3518306A (en) * 1968-02-19 1970-06-30 American Cyanamid Co 7- and/or 9-(n-nitrosoalkylamino)-6-demethyl-6-deoxytetracyclines
US4806529A (en) * 1982-11-18 1989-02-21 Trustees Of Tufts College, Tufts University Tetracycline activity enhancement
SG52361A1 (en) * 1991-10-04 1998-09-28 American Cyanamid Co Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Richard C. Larock, Comprehersive Organic Transformatins. VCH Publishers, 411 - 415, 1989. *

Also Published As

Publication number Publication date
LV12273B (en) 1999-11-20
EP0582790B1 (en) 1998-12-23
KR940003923A (ko) 1994-03-14
ZA935891B (en) 1994-03-09
CA2103837A1 (en) 1994-02-14
FI933566L (fi) 1994-02-14
CZ286261B6 (cs) 2000-02-16
NO932870D0 (no) 1993-08-12
HUT64941A (en) 1994-03-28
NZ248358A (en) 1996-04-26
US5284963A (en) 1994-02-08
ES2125927T3 (es) 1999-03-16
FI933566A0 (fi) 1993-08-12
JP3590643B2 (ja) 2004-11-17
CN1083047A (zh) 1994-03-02
SG68556A1 (en) 1999-11-16
PL300064A1 (en) 1994-02-21
AU674689B2 (en) 1997-01-09
PL173923B1 (pl) 1998-05-29
FI115722B (fi) 2005-06-30
CZ157793A3 (en) 1994-03-16
IL106674A0 (en) 1993-12-08
HU222886B1 (hu) 2003-12-29
DE69322708T2 (de) 1999-04-29
DE69322708D1 (de) 1999-02-04
HU9302331D0 (en) 1993-10-28
JPH06184075A (ja) 1994-07-05
MX9304649A (es) 1994-02-28
IL119551A0 (en) 1997-02-18
LV12273A (lv) 1999-05-20
KR100250603B1 (ko) 2000-04-01
IL106674A (en) 1998-07-15
TW221285B (enExample) 1994-02-21
CN1037680C (zh) 1998-03-11
PL173606B1 (pl) 1998-03-31
EP0582790A1 (en) 1994-02-16
AU4460393A (en) 1994-02-17
CA2103837C (en) 2004-10-05
GR3029764T3 (en) 1999-06-30
IL119551A (en) 2003-02-12
SK281698B6 (sk) 2001-07-10
DK0582790T3 (da) 1999-08-23
SK84993A3 (en) 1994-06-08
PH30150A (en) 1997-01-21
NO932870L (no) 1994-02-14
ATE174903T1 (de) 1999-01-15
NO303574B1 (no) 1998-08-03

Similar Documents

Publication Publication Date Title
RU2111958C1 (ru) Способ получения 7-(замещенный)-9-[(замещенный глицил)амидо]-6-диметил-6-деокситетрациклинов
AU673366B2 (en) Novel 7-(substituted)-8-(substituted-9-{(substituted glycyl) amido}-6-demethyl-6-deoxytetracyclines
KR890000763B1 (ko) 4'-데메틸-에피포도필로톡신-β-D-에틸리덴-글루코사이드 및 그의 아실유도체의 제조방법
SU1333234A3 (ru) Способ получени производных N-фенилбензамида или их солей
SK85693A3 (en) 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6- -deoxytetracyclines
JP7685292B2 (ja) エドキサバンの鍵中間体及びその合成方法
FI84910C (fi) Vinsyramonoestrar av optiskt aktiva alkanolaminer och foerfarande foer deras framstaellning.
JP3180192B2 (ja) ジチオカルバミン酸の塩類、その製造方法及び該ジチオカルバミン酸の塩類を使用するイソチオシアネート類の製造方法
CZ288587B6 (cs) Způsob výroby dichloridu kyseliny 5-amino-2,4,6-trijodizoftalové
DE69821483T2 (de) Verfahren zur gewinnung von chinaprylhydrochlorid und solvaten, die bei der isolierung und reinigung von chinaprylhydrochlorid nützlich sind
IL311879A (en) Method for producing compound or pharmaceutically acceptable salt thereof
US2578696A (en) N-(2-chloroethyl)-n-piperonyl amines
AU2008333153A1 (en) Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)- carbamoyl-7-oxo-2,6-diaza-bicyclo[3.2.0.]heptane-6-sulfonic acid derivatives
JPH031317B2 (enExample)
JP2013512883A (ja) コンブレタスタチン誘導体調製方法
HU219463B (hu) Új 9-[(halogén-acil-amino]-8-(szubsztituált)-6-dezmetil-6-dezoxitetraciklin-vegyületek és eljárás előállításukra
JPH05255230A (ja) 新規なβ−アラニン誘導体およびその製造方法並びにグルタミン酸遮断剤の製造方法
KR20010068677A (ko) 3-할로메틸세펨의 제조방법
JPH0527632B2 (enExample)
KR19990041199A (ko) 세팔로스포린 중간체의 부분입체 이성질체의 합성과 분리방법
HU213404B (en) Process for producing 7-(substituted)-9-[(halogeno-acyl)-amido]-6-demethyl-6-deoxytetracyclin derivatives
BG61303B1 (bg) метод за получаване на n-(3-(3-(1-пиперидинилметил)фенокси) пропил)ацетоксиацетамид хидрохлорид

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20100813